Sulfadiazine argentique : interactions médicamenteuses

Sulfadiazine argentique (Silvadene, SSD), sulfamide, présente 73 interactions documentées dans les notices FDA et les fiches d'information que nous indexons : 28 de niveau majeur, 29 de niveau modéré, 16 de niveau mineur et 0 cas où une notice ne signale aucune interaction significative. Chaque entrée ci-dessous cite la phrase sur laquelle elle repose. Cette page consacrée à un médicament est un point de départ, pas un verdict sur votre situation.

Interactions d'après la notice

Interactions majeures (28)

  • Aténolol et chlortalidonebêtabloquantMajeure

    CONTRAINDICATIONS Atenolol and chlorthalidone is contraindicated in patients with: sinus bradycardia; heart block greater than first degree; cardiogenic shock; overt cardiac failure (See WARNINGS ); anuria; hypersensitivity to this product or to sulfonamide-derived drugs. (notice Aténolol et chlortalidone, Contre-indications)

  • Bénazépril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs. (notice Bénazépril et hydrochlorothiazide, Contre-indications)

  • CONTRAINDICATIONS Bisoprolol fumarate and hydrochlorothiazide tablets are contraindicated in patients in cardiogenic shock, overt cardiac failure (see WARNINGS ), second or third degree AV block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs. (notice Bisoprolol et hydrochlorothiazide, Contre-indications)

  • Candésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    CONTRAINDICATIONS Candesartan cilexetil and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to candesartan, to hydrochlorothiazide or to other sulfonamide-derived drugs. (notice Candésartan et hydrochlorothiazide, Contre-indications)

  • CélécoxibAINSMajeure

    • In patients who have demonstrated allergic-type reactions to sulfonamides [ see Warnings and Precautions (5.7) ]. (notice Célécoxib, Contre-indications)

  • Chloroprocaïneanesthésique localMajeure

    Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed. (notice Chloroprocaïne, Précautions)

  • Chlorothiazidediurétique thiazidiqueMajeure

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (notice Chlorothiazide, Contre-indications)

  • Chlortalidonediurétique thiazidiqueMajeure

    THALITONE is contraindicated in patients with anuria or hypersensitivity to chlorthalidone or other sulfonamide-derived drugs. (notice Chlortalidone, Contre-indications)

  • CidofovirantiviralMajeure

    Cidofovir injection is contraindicated in patients with a history of clinically severe hypersensitivity to probenecid or other sulfa-containing medications. (notice Cidofovir, Contre-indications)

  • Diclofénamideinhibiteur de l'anhydrase carboniqueMajeure

    KEVEYIS is contraindicated in the following circumstances: Hypersensitivity to dichlorphenamide or other sulfonamides [see Warnings and Precautions (5.1) ] Concomitant use of KEVEYIS and high dose aspirin [see Warnings and Precautions (5.2) and Drug Interactions (7.1) ] Severe pulmonary disease, limiting compensation to metabolic acidosis caused by KEVEYIS [see… (notice Diclofénamide, Contre-indications)

  • Dutastéride et tamsulosineinhibiteur de la 5-alpha-réductaseMajeure

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin-containing products, including JALYN. (notice Dutastéride et tamsulosine, Mises en garde et précautions)

  • Énalapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (notice Énalapril et hydrochlorothiazide, Contre-indications)

  • Fosinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Fosinopril sodium and hydrochlorothiazide is also contraindicated in patients who are hypersensitive to fosinopril, to any other ACE inhibitor, to hydrochlorothiazide, or other sulfonamide-derived drugs, or any other ingredient or component in the formulation. (notice Fosinopril et hydrochlorothiazide, Contre-indications)

  • Glimépiridesulfamide hypoglycémiantMajeure

    • Sulfonamide derivatives: Patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride tablets.Do not use glimepiride tablets in patients who have a history of an allergic reaction to sulfonamide derivatives. (notice Glimépiride, Contre-indications)

  • Glipizidesulfamide hypoglycémiantMajeure

    • Hypersensitivity to sulfonamide derivatives. ▪ Known hypersensitivity to glipizide or any of the product's ingredients ( 4 ). ▪ Hypersensitivity to sulfonamide derivatives ( 4 ). (notice Glipizide, Contre-indications)

  • Hydrochlorothiazidediurétique thiazidiqueMajeure

    In patients with hypersensitivity to sulfonamide-derived drugs. (notice Hydrochlorothiazide, Contre-indications)

  • Indapamidediurétique thiazidiqueMajeure

    Known hypersensitivity to indapamide or to other sulfonamide-derived drugs. (notice Indapamide, Contre-indications)

  • Irbésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (notice Irbésartan et hydrochlorothiazide, Contre-indications)

  • Lisinopril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (notice Lisinopril et hydrochlorothiazide, Contre-indications)

  • MécamylamineantihypertenseurMajeure

    Patients receiving antibiotics and sulfonamides should generally not be treated with ganglion blockers. (notice Mécamylamine, Contre-indications)

  • Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (notice Métoprolol et hydrochlorothiazide, Contre-indications)

  • Olmésartan, amlodipine et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because of the hydrochlorothiazide component, olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet is contraindicated in patients with anuria, hypersensitivity to any component, or hypersensitivity to other sulfonamide-derived drugs. (notice Olmésartan, amlodipine et hydrochlorothiazide, Contre-indications)

  • Pioglitazone et glimépiridethiazolidinedioneMajeure

    Use in patients with known history of an allergic reaction to sulfonamide derivatives. (notice Pioglitazone et glimépiride, Contre-indications)

  • Quinapril et hydrochlorothiazideinhibiteur de l'enzyme de conversion (IEC)Majeure

    Because of the hydrochlorothiazide components, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (notice Quinapril et hydrochlorothiazide, Contre-indications)

  • Spironolactone et hydrochlorothiazideantagoniste de l'aldostéroneMajeure

    CONTRAINDICATIONS Spironolactone and hydrochlorothiazide tablets are contraindicated in patients with anuria, acute renal insufficiency, significant impairment of renal excretory function, hypercalcemia, hyperkalemia, Addison's disease, and in patients who are allergic to thiazide diuretics or to other sulfonamide-derived drugs. (notice Spironolactone et hydrochlorothiazide, Contre-indications)

  • TamsulosinealphabloquantMajeure

    If a patient reports a serious or life-threatening sulfa allergy, caution is warranted when administering tamsulosin hydrochloride capsules. (notice Tamsulosine, Mises en garde et précautions)

  • Triamtérène et hydrochlorothiazidediurétique épargneur de potassiumMajeure

    Hypersensitivity Hypersensitivity to either drug in the preparation or to other sulfonamide-derived drugs is a contraindication. (notice Triamtérène et hydrochlorothiazide, Contre-indications)

  • Valsartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Majeure

    Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. (notice Valsartan et hydrochlorothiazide, Contre-indications)

Interactions modérées (29)

  • AlmotriptantriptanModérée

    Use with caution in patients with a known hypersensitivity to sulfonamides ( 5.8 ) (notice Almotriptan, Mises en garde et précautions)

  • Articaïne et adrénalineanesthésique localModérée

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine… (notice Articaïne et adrénaline, Interactions médicamenteuses)

  • Bromocriptineagoniste de la dopamineModérée

    Therefore, CYCLOSET may increase the unbound fraction of other concomitantly used highly protein-bound therapies (e.g., salicylates, sulfonamides, chloramphenicol and probenecid), which may alter their effectiveness and risk for side effects. (notice Bromocriptine, Interactions médicamenteuses)

  • Bupivacaïne et adrénalineanesthésique localModérée

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent… (notice Bupivacaïne et adrénaline, Interactions médicamenteuses)

  • DarunavirantirétroviralModérée

    Use with caution in patients with a known sulfonamide allergy. (notice Darunavir, Mises en garde et précautions)

  • Darunavir et cobicistatantirétroviralModérée

    Monitor in patients with a known sulfonamide allergy. (notice Darunavir et cobicistat, Mises en garde et précautions)

  • FénoprofèneAINSModérée

    Intervention: Patients receiving hydantoins, sulfonamides, or sulfonylureas should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs. (notice Fénoprofène, Interactions médicamenteuses)

  • FosamprénavirantirétroviralModérée

    Fosamprenavir calcium should be used with caution in patients with a known sulfonamide allergy. (notice Fosamprénavir, Mises en garde et précautions)

  • FosphénytoïneanticonvulsivantModérée

    …voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric acid reducing agents H 2 antagonists (cimetidine), omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen,… (notice Fosphénytoïne, Interactions médicamenteuses)

  • Glibenclamidesulfamide hypoglycémiantModérée

    …Interactions The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, ACE inhibitors, disopyramide, fluoxetine, clarithromycin, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, monoamine oxidase inhibitors, and beta adrenergic blocking agents. (notice Glibenclamide, Interactions médicamenteuses)

  • Glipizide et metforminesulfamide hypoglycémiantModérée

    Glipizide: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs, including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta-adrenergic blocking agents. (notice Glipizide et metformine, Précautions)

  • Insuline asparteinsulineModérée

    Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. (notice Insuline asparte, Interactions médicamenteuses)

  • Insuline dégludecinsulineModérée

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors. (notice Insuline dégludec, Interactions médicamenteuses)

  • Insuline détémirinsulineModérée

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors. (notice Insuline détémir, Interactions médicamenteuses)

  • Insuline glargineinsulineModérée

    …May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors. (notice Insuline glargine, Interactions médicamenteuses)

  • Insuline lisproinsulineModérée

    Clinically Significant Drug Interactions with LYUMJEV Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. (notice Insuline lispro, Interactions médicamenteuses)

  • Insuline rapide (humaine)insulineModérée

    …Receptor Blocking Agents, Disopyramide, Fibrates, Fluoxetine, Monoamine Oxidase Inhibitors, Pentoxifylline, Pramlintide, Salicylates, Somatostatin Analogs (e.g., octreotide), and Sulfonamide Antibiotics Prevention or Management Monitor blood glucose more frequently and modify AFREZZA dosage, as clinically indicated, when used concomitantly with these drugs. (notice Insuline rapide (humaine), Interactions médicamenteuses)

  • Lidocaïne et adrénalineanesthésique localModérée

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent… (notice Lidocaïne et adrénaline, Interactions médicamenteuses)

  • Losartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (notice Losartan et hydrochlorothiazide, Mises en garde et précautions)

  • Mépivacaïneanesthésique localModérée

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine (notice Mépivacaïne, Interactions médicamenteuses)

  • Olmésartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (notice Olmésartan et hydrochlorothiazide, Mises en garde et précautions)

  • PhénytoïneanticonvulsivantModérée

    …voriconazole Antineoplastic agents Capecitabine, fluorouracil Antidepressants Fluoxetine, fluvoxamine, sertraline Gastric acid reducing agents H 2 antagonists (cimetidine), omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen,… (notice Phénytoïne, Interactions médicamenteuses)

  • Prilocaïne et adrénalineanesthésique localModérée

    …procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine The administration… (notice Prilocaïne et adrénaline, Interactions médicamenteuses)

  • ProbénécideModérée

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (notice Probénécide, Interactions médicamenteuses)

  • Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (notice Probénécide et colchicine, Interactions médicamenteuses)

  • PyriméthamineantipaludiqueModérée

    However, the concomitant use of other antifolic drugs or agents associated with myelosuppression including sulfonamides or trimethoprim- sulfamethoxazole combinations, proguanil, zidovudine, or cytostatic agents (e.g., methotrexate), while the patient is receiving pyrimethamine, may increase the risk of bone marrow suppression. (notice Pyriméthamine, Interactions médicamenteuses)

  • Ropivacaïneanesthésique localModérée

    …procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine NAROPIN… (notice Ropivacaïne, Interactions médicamenteuses)

  • Like other sulfonamide-containing drugs, sulfamethoxazole and trimethoprim potentiates the effect of oral hypoglycemics. (notice Sulfaméthoxazole et triméthoprime, Interactions médicamenteuses)

  • Telmisartan et hydrochlorothiazideantagoniste des récepteurs de l'angiotensine II (ARA II)Modérée

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (notice Telmisartan et hydrochlorothiazide, Mises en garde et précautions)

Mentions mineures (16)

  • Acétazolamideinhibiteur de l'anhydrase carboniqueMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • Amoxicillineantibiotique de la famille des pénicillinesMineure

    Other Antibacterials Chloramphenicol, macrolides, sulfonamides, and tetracyclines may interfere with the bactericidal effects of penicillin. (notice Amoxicilline, Interactions médicamenteuses)

  • Ampicillineantibiotique de la famille des pénicillinesMineure

    Bacteriostatic Antibiotics : Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins. (notice Ampicilline, Interactions médicamenteuses)

  • Lack of Effectiveness Methemoglobinemia may not resolve or may rebound after response to treatment with PROVAYBLUE in patients with methemoglobinemia due to aryl amines such as aniline or sulfa drugs such as dapsone. (notice Bleu de méthylène, Mises en garde et précautions)

  • Brinzolamideinhibiteur de l'anhydrase carboniqueMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • Bumétanidediurétique de l'anseMineure

    Allergy to Sulfonamides Patients allergic to sulfonamides may show hypersensitivity to bumetanide. (notice Bumétanide, Mises en garde)

  • Dorzolamideinhibiteur de l'anhydrase carboniqueMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • Dorzolamide et timololinhibiteur de l'anhydrase carboniqueMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • Glibenclamide et metforminesulfamide hypoglycémiantMineure

    Examples: Nonsteroidal anti-inflammatory agents and other highly protein-boind drugs, salicylcates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, beta-adrenergic blocking agents; potentially with ciprofloxacin, micronazole. (notice Glibenclamide et metformine, Interactions médicamenteuses)

  • Méthazolamideinhibiteur de l'anhydrase carboniqueMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • Métolazonediurétique thiazidiqueMineure

    Cross-Allergy Cross-allergy may occur when metolazone tablets, USP, are given to patients known to be allergic to sulfonamide-derived drugs, thiazides, or quinethazone. (notice Métolazone, Mises en garde)

  • Pénicilline Gantibiotique de la famille des pénicillinesMineure

    Drug Interactions Bacteriostatic antibacterials ( i.e. , chloramphenicol, erythromycins, sulfonamides or tetracyclines) may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. (notice Pénicilline G, Interactions médicamenteuses)

  • RépaglinideglinideMineure

    Examples: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, nonsteroidal anti-inflammatory agents (NSAIDs), pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. (notice Répaglinide, Interactions médicamenteuses)

  • SulfadiazinesulfamideMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • SulfasalazinesulfamideMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

  • ZonisamideanticonvulsivantMineure

    There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. (notice Sulfadiazine argentique, Mises en garde et précautions)

Vérifiez Sulfadiazine argentique avec tout ce que vous prenez. Ajoutez votre liste complète ; toutes les paires sont vérifiées en une fois.

Ouvrir dans le vérificateur

Ceci n'est pas un avis médical. Le niveau de gravité reflète la formulation de la notice, pas votre situation. Une alerte « majeure » peut être courante sous surveillance et une alerte « mineure » peut compter à forte dose. Demandez conseil à un pharmacien.